Effectiveness of CES on Emotional and Cellular Wellbeing

Completed · Not applicable

Conditions studied: Anxiety, Depression

In brief

The investigators aim to use a CES (cranial electrotherapy stimulation) intervention to improve emotional well-being by reducing symptoms of anxiety and depression and to assess for changes in markers of cellular health - specifically, telomere length and telomerase activity

Key facts

Study ID

NCT03369418

Run by

University of California, Los Angeles

People needed

44

Starts

2016-03-01

Expected to finish

2018-10-20

Last updated by the study team

2020-08-19

Who can join

Age: 18 and older, up to 40. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Male
• Within the age range of 18-40 years old
• Score 8-14 on either the anxiety or depression HADS scale as defined as mild (8-10) to moderate (11-14)
• Subjects who receive anxiety, depression, psychiatric or mental health treatment (pharmacological or non-pharmacological) must be on a stable regimen for the past 3 months
• No active suicidal ideation or psychosis (including schizophrenia and bipolar disorder)
• No uncontrolled or progressive severe medical illness (e.g., cancer, uncontrolled diabetes mellitus, active cardiac disease)
• No use of a pacemaker or any other implanted electrical device
• No alcohol consumption greater than 2 units daily
• Ability to independently complete the in-person study questionnaires and sign informed consent form (ICF) without assistance
• Willing to comply with all study procedures and be available for the duration of the study
• No participation in another clinical trial study

You may not qualify if…

• Not a male
• Younger than 18 years old or older than 40 years old
• Score ≥15 on either the anxiety or depression HADS scale as defined as severe (15-20)
• Subject who receive anxiety, depression, psychiatric or mental health treatment (pharmacological or non-pharmacological) who have not been on a stable regimen for the past 3 months
• Active suicidal ideation or psychosis (including schizophrenia and bipolar disorder)
• History of inpatient treatment or suicidal ideation within the last year
• Use of a pacemaker or any other implanted electrical device
• Unable to independently complete the in-person study questionnaires and sign ICF due to impaired cognitive function
• Unwilling to comply with all study procedures
• Unavailable for the duration of the study
• Current participation in another clinical trial study
• Any other condition that the investigator believes would jeopardize the safety or rights of the subject or would render the subject unable to comply with the study protocol or make use of acquired data non-analyzable

Where it is running

• University of California, Los Angeles (UCLA) — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.